Last reviewed · How we verify
NCT07083271: FIN-CARE
Financial Toxicity and Quality of Life in Hospitalized Cancer Patients: A Multicenter Study
trial testing Administration of validated questionnaires with established Turkish versions in Financial Toxicity in 756 participants. Completed in 19 February 2026.
22 October 2025
Quick facts
| Lead sponsor | Ankara Etlik City Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 756 |
| Start date | 1 August 2025 |
| Primary completion | 22 October 2025 |
| Estimated completion | 19 February 2026 |
| Sites | 3 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Administration of validated questionnaires with established Turkish versions
Conditions studied
- Financial Toxicity — all drugs for Financial Toxicity →
- Cancer Patients — all drugs for Cancer Patients →
Sponsor
Ankara Etlik City Hospital
Who can join
18 and older, any sex, with Financial Toxicity or Cancer Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multicenter, cross-sectional observational study aims to evaluate the impact of financial toxicity on caregiver burden, quality of life, and emotional distress among hospitalized adult cancer patients. Participants will complete validated Turkish versions of the Zarit Caregiver Burden Scale, the EORTC QLQ-C30, and the Hospital Anxiety and Depression Scale (HADS). Financial toxicity will be assessed through indicators such as household income, treatment-related costs, and insurance coverage. Informed consent will be obtained from all participants. The study will not impose any financial burden on the participants or the hospital. Data collection is planned between August 1, 2025 and January 15, 2026 at three tertiary centers: Etlik City Hospital, Gazi University Faculty of Medicine, and Kocaeli University Faculty of Medicine in Turkey. The findings are expected to contribute to the development of targeted support strategies for patients and caregivers in oncology settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07083271
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Financial Toxicity
Currently open trials in the same condition.
- NCT07215611 — Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas · recruiting
- NCT07281287 — Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation · NA · recruiting
- NCT06461780 — Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy · NA · recruiting
- NCT04766190 — DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer · NA · recruiting
Other Ankara Etlik City Hospital trials
Trials by the same sponsor.
- NCT07472452 — MULTIMODAL APPROACH IN THE DIAGNOSIS OF SEPTIC AKI · not yet recruiting
- NCT07488442 — Efficacy of Cognitive Behavioral Therapy Administered in Patients With Dyssynergic Defecation · NA · recruiting
- NCT07488455 — Effectiveness of Video-Based or Written Pelvic Floor Education in Postpartum Women · NA · recruiting
- NCT07375173 — ORI-Guided FiO₂ Titration in Prone Spine Surgery: Impact on Postoperative Atelectasis Assessed by Lung Ultrasound · NA · not yet recruiting
- NCT07456202 — Menstrual Status, Anesthetic Consumption, and PONV · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07083271 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Etlik City Hospital
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07083271.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing